Olivia Dvorak (@oliviadvorak) 's Twitter Profile
Olivia Dvorak

@oliviadvorak

Artist | Songwriter | Guitarist | On a journey to discover the human heart

ID: 1138140553

linkhttp://oliviadvorak.com calendar_today31-01-2013 22:54:54

2,2K Tweet

2,2K Followers

2,2K Following

Olivia Dvorak (@oliviadvorak) 's Twitter Profile Photo

$PTN Target price: $25 Support level: $21 The Phase III clinical trial data for this peptide drug exceeded expectations, and the company will submit a breakthrough therapy application to the U.S. Food and Drug Administration (FDA) next month.

$PTN

Target price: $25  Support level: $21  The Phase III clinical trial data for this peptide drug exceeded expectations, and the company will submit a breakthrough therapy application to the U.S. Food and Drug Administration (FDA) next month.
Olivia Dvorak (@oliviadvorak) 's Twitter Profile Photo

$ENVB Short-term trading target price: $15-20, Stop-loss price: $8 The EVM301 patent (N-heterocyclic tryptamine derivatives) has been approved by the U.S. Patent and Trademark Office. Buy now! ENVB is a high-yield stock suitable for short-term trading.

$ENVB
Short-term trading target price: $15-20, Stop-loss price: $8
The EVM301 patent (N-heterocyclic tryptamine derivatives) has been approved by the U.S. Patent and Trademark Office. Buy now! ENVB is a high-yield stock suitable for short-term trading.
Olivia Dvorak (@oliviadvorak) 's Twitter Profile Photo

$PL From a technical perspective, this is a very standard "W-shaped bottom + platform breakout + pullback confirmation" pattern. The entire accumulation-consolidation-rally cycle fits perfectly. Aggressive traders can enter the market directly at today's closing price; any price

$PL
From a technical perspective, this is a very standard "W-shaped bottom + platform breakout + pullback confirmation" pattern. The entire accumulation-consolidation-rally cycle fits perfectly.

Aggressive traders can enter the market directly at today's closing price; any price
Olivia Dvorak (@oliviadvorak) 's Twitter Profile Photo

If you were following the news late last night, the Washington Post reported that "Trump's aides are planning to order the reclassification of marijuana as a Schedule III controlled substance, placing it in the same category as prescription painkillers." This caused all cannabis

If you were following the news late last night, the Washington Post reported that "Trump's aides are planning to order the reclassification of marijuana as a Schedule III controlled substance, placing it in the same category as prescription painkillers." This caused all cannabis
Olivia Dvorak (@oliviadvorak) 's Twitter Profile Photo

$SNDL The stock price has recently formed a symmetrical triangle pattern, with the upper boundary being a descending trendline (yellow) and the lower boundary being an ascending support line (blue), a typical bullish consolidation structure. It has broken above the upper

$SNDL
The stock price has recently formed a symmetrical triangle pattern, with the upper boundary being a descending trendline (yellow) and the lower boundary being an ascending support line (blue), a typical bullish consolidation structure. It has broken above the upper
Olivia Dvorak (@oliviadvorak) 's Twitter Profile Photo

$AAL Key support level: $15.30-$15.50 Resistance level: $17.00-$17.50 Target price may be revised upwards to $19. If the stock price breaks above $17 with increased trading volume, and the price is above the 50-day moving average, with the short-term RSI indicator approaching the

$AAL
Key support level: $15.30-$15.50
Resistance level: $17.00-$17.50
Target price may be revised upwards to $19.
If the stock price breaks above $17 with increased trading volume,
and the price is above the 50-day moving average, with the short-term RSI indicator approaching the
Olivia Dvorak (@oliviadvorak) 's Twitter Profile Photo

$MLKN Target Price: $20-22 Stop Loss: $16.30 (This is a support level; close your position if the price breaks below this level to avoid further declines.) The company's earnings exceeded expectations, and strong order growth indicates significant potential for a short-term

$MLKN
Target Price: $20-22
Stop Loss: $16.30 (This is a support level; close your position if the price breaks below this level to avoid further declines.) The company's earnings exceeded expectations, and strong order growth indicates significant potential for a short-term
Olivia Dvorak (@oliviadvorak) 's Twitter Profile Photo

Summary of Trump's speech: "The economy is better than ever before, prices going down, all of my friends tell me that" Horrible gaslighting, his poll numbers will continue to drop like a rock

Summary of Trump's speech: "The economy is better than ever before, prices going down, all of my friends tell me that"  Horrible gaslighting, his poll numbers will continue to drop like a rock